LENZ vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

LENZ

51.7
AI Score
VS
LENZ Wins

CBIO

46.3
AI Score

Investment Advisor Scores

LENZ

52score
Recommendation
STRONG BUY

CBIO

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LENZ CBIO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -72.9% 0.0% CBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 51.7/100 46.3/100 LENZ
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD LENZ

Relative Price Performance (Last 90 Days)

LENZ 1M: +17.2% · 3M: -15.0% CBIO 1M: +19.3% · 3M: -12.4%

Current Technical Phase

LENZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.3 · Price: $4.02

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.3 · Price: $15.01

Fundamentals Snapshot

Metric LENZ CBIO
Market Cap — —
Forward P/E -3.1 -5.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.7% 0.0%
Gross Margin 0.8% 1.0%
Operating Margin -9.7% -14.3%
EPS -4.53 -7.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LENZ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.